Aurinia Pharmaceuticals Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Edmonton, Alberta, Canada
AUPH chart
What traders are saying about $AUPH
Latest postsAurinia Pharmaceuticals Inc. news
- Will Raised Revenue Guidance Change Aurinia Pharmaceuticals Stock Narrative
Simply Wall St ·
- Aurinia Pharmaceuticals Inc (0UJF.IL) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Is Aurinia Pharmaceuticals (AUPH) Undervalued On Raised Guidance And Stronger LUPKYNIS Sales?
Simply Wall St ·
- Aurinia Pharmaceuticals Inc (IKAP.SG) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
- TD Cowen maintains Buy on Aurinia Pharmaceuticals, lifts price target to $18
scanx.trade ·
- Earnings Beat May Change The Case For Aurinia Pharmaceuticals Stock
Yahoo Finance ·
- Aurinia Pharmaceuticals Inc. (AUPH) Seasonal returns chart
Yahoo Finance UK ·
- Aurinia Pharmaceuticals stock gets lift from higher 2026 outlook
ad-hoc-news.de ·
- Analysts Are Bullish on These Healthcare Stocks: Aurinia Pharmaceuticals (AUPH), AbbVie (ABBV)
The Globe and Mail ·
- One Aurinia Pharmaceuticals Insider Has Reduced Their Stake
Moomoo ·
- Bloom Burton Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Maintains Target Price $21
Moomoo ·
- Aurinia Pharmaceuticals (AUPH) Tops Q3 Earnings Estimates
Yahoo Finance ·
Aurinia Pharmaceuticals Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $283.1M | $235.1M | $175.5M | $134.0M |
| Net income | $287.2M | $5.8M | -$78.0M | -$108.2M |
| Diluted EPS | $2.07 | $0.04 | $-0.54 | $-0.76 |
| Total assets (year end) | $751.6M | $550.6M | $548.1M | $470.9M |
| Cash and equivalents (year end) | $80.2M | $83.4M | $48.8M | $94.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Aurinia Pharmaceuticals Inc.
- Ticker
- AUPH (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Edmonton, Alberta, Canada
- Fiscal year end
- December 31
- SEC CIK
- 1600620
Frequently asked questions
What exchange is Aurinia Pharmaceuticals Inc. listed on?
Aurinia Pharmaceuticals Inc. trades on the Nasdaq under the ticker symbol AUPH.
What industry is Aurinia Pharmaceuticals Inc. in?
Aurinia Pharmaceuticals Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Aurinia Pharmaceuticals Inc. headquartered?
Aurinia Pharmaceuticals Inc.'s business address on file with the SEC is in Edmonton, Alberta, Canada.
When does Aurinia Pharmaceuticals Inc.'s fiscal year end?
Aurinia Pharmaceuticals Inc.'s fiscal year ends on December 31.
How much revenue did Aurinia Pharmaceuticals Inc. report?
Aurinia Pharmaceuticals Inc. reported $283.1M in revenue for calendar year 2025, according to its SEC filings.